(NASDAQ: YTEN) Yield10 Bioscience's forecast annual revenue growth rate of 462.72% is forecast to beat the US Agricultural Inputs industry's average forecast revenue growth rate of 22.09%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Yield10 Bioscience's revenue in 2024 is $147,000.On average, 1 Wall Street analysts forecast YTEN's revenue for 2024 to be $40,136,337, with the lowest YTEN revenue forecast at $40,136,337, and the highest YTEN revenue forecast at $40,136,337. On average, 1 Wall Street analysts forecast YTEN's revenue for 2025 to be $160,305,726, with the lowest YTEN revenue forecast at $160,305,726, and the highest YTEN revenue forecast at $160,305,726.
In 2026, YTEN is forecast to generate $320,491,643 in revenue, with the lowest revenue forecast at $320,491,643 and the highest revenue forecast at $320,491,643.